4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytokine changes in castrate metastatic prostate cancer (CPMC) patients (pts) treated with ipilimumab (Ipi)
    Meeting Abstract

    Yuan, J.; Orlandi, F.; Jefferson, M.; Li, H.; Gallardo, H.; Ku, G.; Wolchok, J.; Scher, H.; Allison, J.; Slovin, S. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort of HDGC patients with and without CDH1 mutation and patients with sporadic GC
    Meeting Abstract

    Shah, M. A.; Pristyazhnyuk, Y.; Jhawer, M.; Coombes, S.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K. M.; Coit, D.; Kelsen, D. P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07, and C89803
    Meeting Abstract

    Sargent, D. J.; Yothers, G.; Van Cutsem, E.; Cassidy, J.; Saltz, L.; Wolmark, N.; Shi, Q.; Buyse, M.; de Gramont, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety and efficacy of AMG 655 plus modified FOLFOX6 (mFOLFOX6) and bevacizumab (B) for the first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Saltz, L.; Infante, J.; Schwartzberg, L.; Stephenson, J.; Rocha-Lima, C.; Galimi, F.; Dillingham, K.; Hsu, M.; Wiezorek, J.; Fuchs, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Metastatic gastroesophageal cancer and long-term survival
    Meeting Abstract

    Power, D. G.; Jhawer, M.; Feilchenfeldt, J. W.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Integrated safety findings with tesetaxel, an orally administered taxane, in patients (pts) with gastric, colon, breast, and nonsmall cell lung cancer: Phase II results
    Meeting Abstract

    Novick, S. C.; Wu, J.; Ilson, D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Impact of older age on the efficacy of newer adjuvant therapies in > 12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database
    Meeting Abstract

    McCleary, N. A. J.; Meyerhardt, J.; Green, E.; Yothers, G.; de Gramont, A.; Van Cutsem, E.; O'Connell, M.; Twelves, C.; Saltz, L.; Sargent, D.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists
    Meeting Abstract

    Love, N.; Ziel, K. A.; Bylund, C.; Elder, M.; Ellis, L. M.; Grothey, A.; Meropol, N. J.; Paley, D.; Ravdin, P. M.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial
    Meeting Abstract

    Kelsen, D.; Jhawer, M.; Ilson, D.; Tse, A.; Randazzo, J.; Robinson, E.; Capanu, M.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save